Absorption, metabolism, excretion and pharmacokinetics of a single dose [14C]AZD2014 followed by a multiple dose phase

Trial Identifier:	D2270C00015
Sponsor:	AstraZeneca
Collaborator:	Quintiles
NCTID::	NCT02640755
Start Date:	January 2016
Primary Completion Date:	December 2016
Study Completion Date:	July 2017
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English language

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Manchester, United Kingdom, M20 4BX

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.